Kopran - Quaterly Results

10 Feb 2023 Evaluate
The revenue zoomed 24.54% to Rs. 679.64 millions for the quarter ended December 2022 as compared to Rs. 545.73 millions during the corresponding quarter last year.Profit after tax for the quarter ended December 2022 reported a huge growth of 74.09% to Rs. 40.44  millions from Rs. 23.23 millions.The company reported a good operating profit of 72.63 millions compared to 50.34 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 679.64 545.73 24.54 1927.67 1400.18 37.67 2045.20 2228.33 -8.22
Other Income 11.60 15.80 -26.58 160.71 59.03 172.25 80.27 104.14 -22.92
PBIDT 72.63 50.34 44.28 345.62 144.79 138.70 234.40 406.14 -42.29
Interest 7.22 9.75 -25.95 18.30 21.56 -15.12 29.53 38.07 -22.43
PBDT 65.41 40.59 61.15 327.32 123.23 165.62 204.87 368.07 -44.34
Depreciation 11.19 10.98 1.91 33.23 32.63 1.84 43.23 41.03 5.36
PBT 54.22 29.61 83.11 294.09 90.60 224.60 161.64 327.04 -50.57
TAX 13.78 6.38 115.99 36.74 20.90 75.79 44.20 92.33 -52.13
Deferred Tax 0.45 1.31 -65.65 -2.31 5.07 -145.56 6.73 34.76 -80.64
PAT 40.44 23.23 74.09 257.35 69.70 269.23 117.44 234.71 -49.96
Equity 482.11 432.52 11.47 482.11 432.52 11.47 482.12 432.52 11.47
PBIDTM(%) 10.69 9.22 15.85 17.93 10.34 73.39 11.46 18.23 -37.12

Kopran Share Price

135.60 -4.10 (-2.93%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×